Neural Induction with Neurogenin 1 Enhances the Therapeutic Potential of Mesenchymal Stem Cells in an Amyotrophic Lateral Sclerosis Mouse Model

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Cell Transplantation

• Publication date

  2013-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3727/096368912X637019PMID 22472631
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Transplantation of Mesenchymal Stem Cells Exerts a Greater Long-Term Effect than Bone Marrow Mononuclear Cells in a Chronic Myocardial Infarction Model in Rat

  2010cited by this paper
• Distribution, Differentiation, and Survival of Intravenously Administered Neural Stem Cells in a Rat Model of Amyotrophic Lateral Sclerosis

  2010cited by this paper
• Human umbilical cord blood treatment in a mouse model of ALS : optimization of cell dose

  2009cited by this paper
• Multiple administrations of human marrow stromal cells through cerebrospinal fluid prolong survival in a transgenic mouse model of amyotrophic lateral sclerosis.

  2009cited by this paper
• ALS-causing SOD1 mutants generate vascular changes prior to motor neuron degeneration

  2008cited by this paper
• Human mesenchymal stem cell transplantation extends survival, improves motor performance and decreases neuroinflammation in mouse model of amyotrophic lateral sclerosis.

  2008cited by this paper
• Bone Marrow Mesenchymal Stem Cells from Healthy Donors and Sporadic Amyotrophic Lateral Sclerosis Patients

  2008cited by this paper
• Mesenchymal stem cells for treatment of myocardial infarction.

  2008cited by this paper
• Neural Induction with Neurogenin1 Increases the Therapeutic Effects of Mesenchymal Stem Cells in the Ischemic Brain

  2008cited by this paper
• Stem cell treatment in Amyotrophic Lateral Sclerosis.

  2008cited by this paper
• Effects of estrogen on lifespan and motor functions in female hSOD1 G93A transgenic mice.

  2008cited by this paper
• Mesenchymal stem cells promote proliferation of endogenous neural stem cells and survival of newborn cells in a rat stroke model

  2008cited by this paper
• Human Umbilical Cord Blood Treatment in a Mouse Model of ALS: Optimization of Cell Dose

  2008cited by this paper
• Intrathecal application of neuroectodermally converted stem cells into a mouse model of ALS: limited intraparenchymal migration and survival narrows therapeutic effects

  2007cited by this paper
• Human mesenchymal stromal cells ameliorate the phenotype of SOD1-G93A ALS mice.

  2007cited by this paper
• Neural stem cells LewisX+ CXCR4+ modify disease progression in an amyotrophic lateral sclerosis model.

  2007cited by this paper
• Adult Olfactory Bulb Neural Precursor Cell Grafts Provide Temporary Protection From Motor Neuron Degeneration, Improve Motor Function, and Extend Survival in Amyotrophic Lateral Sclerosis Mice

  2007cited by this paper
• Multilineage Potential of Stable Human Mesenchymal Stem Cell Line Derived from Fetal Marrow

  2007cited by this paper
• Human Neural Stem Cell Grafts Ameliorate Motor Neuron Disease in SOD-1 Transgenic Rats

  2006cited by this paper
• Multiple transplants of hNT cells into the spinal cord of SOD1 mouse model of familial amyotrophic lateral sclerosis

  2006cited by this paper
• Implantation of BM mesenchymal stem cells into injured spinal cord elicits de novo neurogenesis and functional recovery: evidence from a study in rhesus monkeys.

  2006cited by this paper
• Bone marrow stromal cells infused into the cerebrospinal fluid promote functional recovery of the injured rat spinal cord with reduced cavity formation

  2006cited by this paper
• Migration of Bone Marrow and Cord Blood Mesenchymal Stem Cells In Vitro Is Regulated by Stromal‐Derived Factor‐1‐CXCR4 and Hepatocyte Growth Factor‐c‐met Axes and Involves Matrix Metalloproteinases

  2006cited by this paper
• Combined Immunosuppressive Agents or CD4 Antibodies Prolong Survival of Human Neural Stem Cell Grafts and Improve Disease Outcomes in Amyotrophic Lateral Sclerosis Transgenic Mice

  2006cited by this paper
• Acute injury directs the migration, proliferation, and differentiation of solid organ stem cells: evidence from the effect of hypoxia-ischemia in the CNS on clonal "reporter" neural stem cells.

  2006cited by this paper
• Lumbar Puncture Delivery of Bone Marrow Stromal Cells in Spinal Cord Contusion: A Novel Method for Minimally Invasive Cell Transplantation

  2006cited by this paper
• Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas.

  2005cited by this paper
• cAMP induces neuronal differentiation of mesenchymal stem cells via activation of extracellular signal-regulated kinase/MAPK

  2005cited by this paper
• Autologous mesenchymal stem cell transplantation in stroke patients

  2005cited by this paper
• Optimal methods to characterize the G93A mouse model of ALS

  2005cited by this paper
• Mesenchymal stem cells that produce neurotrophic factors reduce ischemic damage in the rat middle cerebral artery occlusion model.

  2005cited by this paper
• Allogeneic Bone Marrow-Derived Mesenchymal Stromal Cells Promote the Regeneration of Injured Skeletal Muscle without Differentiation into Myofibers

  2004cited by this paper
• Induction of bone marrow stromal cells to neurons: Differentiation, transdifferentiation, or artifact?

  2004cited by this paper
• Reevaluation of in vitro differentiation protocols for bone marrow stromal cells: Disruption of actin cytoskeleton induces rapid morphological changes and mimics neuronal phenotype

  2004cited by this paper
• Temporal gene expression patterns in G93A/SOD1 mouse

  2004cited by this paper
• Bone marrow stromal cells infused into the cerebrospinal fluid promote functional recovery of the injured rat spinal cord with reduced cavity formation.

  2004cited by this paper
• Intravenous Administration of Marrow Stromal Cells (MSCs) Increases the Expression of Growth Factors in Rat Brain after Traumatic Brain Injury

  2004cited by this paper
• Expression of chemokine receptors CXCR4, CCR2, CCR5 and CX3CR1 in neural progenitor cells isolated from the subventricular zone of the adult rat brain.

  2004cited by this paper
• Stem‐cell plasticity and therapy for injuries of the peripheral nervous system

  2004cited by this paper
• Effect of transgene copy number on survival in the G93A SOD1 transgenic mouse model of ALS.

  2004cited by this paper
• Migration of Mesenchymal Stem Cells Through Cerebrospinal Fluid into Injured Spinal Cord Tissue

  2004cited by this paper
• Recent advances in amyotrophic lateral sclerosis research

  2003cited by this paper
• Assessing disease onset and progression in the SOD1 mouse model of ALS

  2003cited by this paper
• Marrow Stromal Cells, Mitosis, and Neuronal Differentiation: Stem Cell and Precursor Functions

  2003cited by this paper
• Gene expression profile of mouse bone marrow stromal cells determined by cDNA microarray analysis

  2003cited by this paper
• Of mice and men: Reconciling preclinical ALS mouse studies and human clinical trials

  2003cited by this paper
• [Migration and differentiation of human bone marrow mesenchymal stem cells in the rat brain].

  2003cited by this paper
• Treatment of traumatic brain injury in adult rats with intravenous administration of human bone marrow stromal cells.

  2003cited by this paper
• Ischemic cerebral tissue and MCP-1 enhance rat bone marrow stromal cell migration in interface culture.

  2002cited by this paper
• MCP-1, MIP-1, IL-8 and Ischemic Cerebral Tissue Enhance Human Bone Marrow Stromal Cell Migration in Interface Culture

  2002cited by this paper
• Human bone marrow stem cells exhibit neural phenotypes and ameliorate neurological deficits after grafting into the ischemic brain of rats.

  2002cited by this paper
• Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery

  2002cited by this paper
• Mitochondrial involvement in amyotrophic lateral sclerosis.

  2002cited by this paper
• Inflammatory processes in amyotrophic lateral sclerosis

  2002cited by this paper
• Positive effect of transplantation of hNT neurons (NTera 2/D1 cell-line) in a model of familial amyotrophic lateral sclerosis.

  2002cited by this paper
• Cytokine upregulation in a murine model of familial amyotrophic lateral sclerosis.

  2001cited by this paper
• In vitro differentiation of human marrow stromal cells into early progenitors of neural cells by conditions that increase intracellular cyclic AMP.

  2001cited by this paper
• Treatment of Traumatic Brain Injury in Adult Rats with Intravenous Administration of Human Bone Marrow Stromal Cells

  2001cited by this paper
• Intracerebral transplantation of bone marrow stromal cells in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.

  2001cited by this paper
• Intraspinal implantation of hNT neurons into SOD1 mice with apparent motor deficit

  2001cited by this paper
• Immune reactivity in a mouse model of familial ALS correlates with disease progression

  2001cited by this paper
• Adult bone marrow stromal cells administered intravenously to rats after traumatic brain injury migrate into brain and improve neurological outcome

  2001cited by this paper
• hNT neurons delay onset of motor deficits in a model of amyotrophic lateral sclerosis.

  2001cited by this paper
• Adult rat and human bone marrow stromal cells differentiate into neurons

  2000cited by this paper
• Amyotrophic lateral sclerosis: pathogenesis.

  2000cited by this paper
• Detection and cellular localization of enterovirus RNA sequences in spinal cord of patients with ALS

  2000cited by this paper
• Reactive astrocytes express p53 in the spinal cord of transgenic mice expressing a human Cu/Zn SOD mutation.

  1999cited by this paper
• Selective impairment of fast anterograde axonal transport in the peripheral nerves of asymptomatic transgenic mice with a G93A mutant SOD1 gene.

  1999cited by this paper
• Expression of Chemokine Receptors in the Rat Brain a

  1999cited by this paper
• S-100beta protein is upregulated in astrocytes and motor neurons in the spinal cord of patients with amyotrophic lateral sclerosis.

  1999cited by this paper
• S-100β protein is upregulated in astrocytes and motor neurons in the spinal cord of patients with amyotrophic lateral sclerosis

  1999cited by this paper
• Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS

  1998cited by this paper
• Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS.

  1998cited by this paper
• Glutamate, excitotoxicity and amyotrophic lateral sclerosis

  1997cited by this paper
• Quantitative motor assessment in FALS mice: a longitudinal study

  1997cited by this paper
• The use of transgenic mouse models of amyotrophic lateral sclerosis in preclinical drug studies.

  1997cited by this paper
• Autoimmunity as an etiological factor in sporadic amyotrophic lateral sclerosis.

  1995cited by this paper
• Overview of motor neuron disease: classification and nomenclature.

  1995cited by this paper
• Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation.

  1994influential reference
• Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis.

  1993cited by this paper
• Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis.

  1993cited by this paper
• Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis

  1993cited by this paper

• Current status and new avenues of stem cell-based preclinical and therapeutic approaches in amyotrophic lateral sclerosis

  2024cites this paper
• Stem Cell-Based Therapeutic Approaches in Genetic Diseases.

  2023cites this paper
• Delayed onset, immunomodulation, and lifespan improvement of SOD1G93A mice after intravenous injection of human mesenchymal stem cells derived from adipose tissue.

  2022cites this paper
• Potential of Cellular Therapy for ALS: Current Strategies and Future Prospects

  2022cites this paper
• The therapeutic potential of exogenous adult stem cells for the injured central nervous system

  2020cites this paper
• Mesenchymal stem cells as a multimodal treatment for nervous system diseases

  2020cites this paper
• Mesenchymal stromal cells (MSCs) for neurodegenerative disease: A promising frontier.

  2020cites this paper
• Stem Cell-based Therapy for Neurodegenerative Diseases

  2020cites this paper
• Stem Cell Transplantation for Amyotrophic Lateral Sclerosis.

  2020cites this paper
• Mesenchymal Stem Cells: A Potential Therapeutic Approach for Amyotrophic Lateral Sclerosis?

  2019cites this paper
• Non-thermal atmospheric pressure plasma is an excellent tool to activate proliferation in various mesoderm-derived human adult stem cells.

  2019cites this paper
• Chapter 9 – Stem Cell Therapy for Amyotrophic Lateral Sclerosis

  2017cites this paper
• The use of mesenchymal stem cells (MSCs) for amyotrophic lateral sclerosis (ALS) therapy – a perspective on cell biological mechanisms

  2017cites this paper
• Advances, challenges and future directions for stem cell therapy in amyotrophic lateral sclerosis

  2017influential citation
• Effects of Adenoviral Gene Transduction on the Stemness of Human Bone Marrow Mesenchymal Stem Cells

  2017cites this paper
• Mesenchymal Stem Cells in the Treatment of Amyotrophic Lateral Sclerosis.

  2016cites this paper
• Stem Cells for Amyotrophic Lateral Sclerosis

  2016cites this paper
• Transplantation of bone marrow mononuclear cells prolongs survival, delays disease onset and progression and mitigates neuronal loss in pre-symptomatic, but not symptomatic ALS mice.

  2016cites this paper
• Genetic Engineering of Mesenchymal Stem Cells for Regenerative Medicine

  2015cites this paper
• Stem cell therapy for amyotrophic lateral sclerosis

  2015cites this paper
• Recent Advances and the Future of Stem Cell Therapies in Amyotrophic Lateral Sclerosis

  2015cites this paper
• Notch pathway is activated in cell culture and mouse models of mutant SOD1-related familial amyotrophic lateral sclerosis, with suppression of its activation as an additional mechanism of neuroprotection for lithium and valproate.

  2015cites this paper
• Concise Review: Stem Cell Therapies for Amyotrophic Lateral Sclerosis: Recent Advances and Prospects for the Future

  2014cites this paper
• Stem Cell Therapies for Amyotrophic Lateral Sclerosis : Recent Advances and Prospects for the Future

  2014cites this paper
• Multiple systemic transplantations of human amniotic mesenchymal stem cells exert therapeutic effects in an ALS mouse model

  2014cites this paper
• Neurogenins in brain development and disease: an overview.

  2014cites this paper
• Amyotrophic Lateral Sclerosis: A Focus on Disease Progression

  2014cites this paper
• A Method for Generate a Mouse Model of Stroke: Evaluation of Parameters for Blood Flow, Behavior, and Survival

  2014cites this paper
• Therapeutic applications of mesenchymal stem cells for amyotrophic lateral sclerosis

  2014cites this paper
• Good manufacturing practice-compliant isolation and culture of human bone marrow mesenchymal stem cells -

  2014cites this paper
• Galanin Promotes Neuronal Differentiation in Murine Subventricular Zone Cell Cultures

  2013cites this paper
• Retrovirus-mediated transduction of a cytosine deaminase gene preserves the stemness of mesenchymal stem cells

  2013cites this paper
• Human umbilical cord mesenchymal stem cell-derived neuron-like cells rescue memory deficits and reduce amyloid-beta deposition in an AβPP/PS1 transgenic mouse model

  2013cites this paper
• Mesenchymal cells in the treatment of spinal cord injury: current & future perspectives.

  2013cites this paper
• POTENCIAL TERAPÊUTICO DAS CÉLULAS MONONUCLEARES DA MEDULA ÓSSEA EM UM MODELO EXPERIMENTAL DE ESCLEROSE LATERAL AMIOTRÓFICA

  2012cites this paper